← Leaderboards
Joia S Mukherjee
Massachusetts General Hospital
$63,608,476
Attributed
$63,608,476
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $10.3M · FY2005–16$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
CDC$63,152,467 · 2
NIH$456,009 · 2
By mechanism
U2G$34,580,185 · 1
U62$28,572,282 · 1
R21$331,458 · 1
K08$124,551 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Bruce D Walker$50,324,331
- John J Iacomini$17,784,530
- Philip J Goulder$10,345,162
- David T Scadden$62,181,067
- Ralph Weissleder$110,468,710
Others in their field
Top investigators on “Aids Therapy”
- Lawrence Corey · Fred Hutchinson Cancer Center$356,191,804
- Constance Ann Benson · University Of California, San Diego$277,003,036
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$262,875,323
- Barbara Driver · Westat, Inc.$205,980,213
- Sharon A Nachman · Johns Hopkins University$193,704,208
- Carol Nesel · Westat$188,148,170
Research focus
Aids TherapyAntiaids AgentBehavioral /Social Science Research TagCellular ImmunityClinical ResearchCytotoxic T LymphocyteEpitope MappingHelper T LymphocyteHigh Risk Behavior /LifestyleHiv InfectionsHuman Immunodeficiency Virus 1Human SubjectLeukocyte Activation /TransformationLymphocyte ProliferationMicroorganism ImmunologySign /SymptomTherapy Design /DevelopmentTissue /Cell Culture
Grant awards (16)
GH11-1193, Haiti: STRENGTHENING INTEGRATED HIV AND CHOLERA CARE,$5,611,784
U2G · FY2016 · GH · contact PI
GH11-1193: STRENGTHENING INTEGRATED HIV AND CHOLERA CARE,$4,584,927
U2G · FY2015 · GH · contact PI
GH11-1193: STRENGTHENING INTEGRATED HIV AND CHOLERA CARE,$2,833,475
U2G · FY2015 · GH · contact PI
GH11-1193, Haiti: STRENGTHENING INTEGRATED HIV AND CHOLERA CARE$1,350,000
U2G · FY2015 · GH · contact PI
GH11-1193: STRENGTHENING INTEGRATED HIV AND CHOLERA CARE,$6,584,925
U2G · FY2014 · GH · contact PI
GH11-1193: STRENGTHENING INTEGRATED HIV AND CHOLERA CARE,$1,015,074
U2G · FY2014 · GH · contact PI
PARTNERS IN HEALTH/ZANMI LASANTE: STRENGTHENING INTEGRATED HIV AND CHOLERA CARE,$7,700,000
U2G · FY2013 · GH · contact PI
GH11-1193: STRENGTHENING INTEGRATED HIV AND CHOLERA CARE,$2,650,000
U2G · FY2013 · GH · contact PI
PARTNERS IN HEALTH/ZANMI LASANTE: STRENGTHENING INTEGRATED HIV AND CHOLERA CARE,$2,250,000
U2G · FY2012 · GH · contact PI
STRENGTHEN & EXPAND ARV TREATMENT THROUGH THE PROVISION OF SOCIAL SUPPORT$3,275,000
U62 · FY2011 · PS · contact PI
PSAA-214: STRENGTHEN & EXPAND ARV TREATMENT THROUGH THE PROV. OF SOCIAL SUPP.$9,722,282
U62 · FY2010 · PS · contact PI
STRENGTHEN & EXPAND ARV TREATMENT THROUGH THE PROVISION OF SOCIAL SUPPORT$7,800,000
U62 · FY2009 · PS · contact PI
STRENGTHEN & EXPAND ARV TREATMENT THROUGH THE PROVISION OF SOCIAL SUPPORT$7,775,000
U62 · FY2008 · PS · contact PI
Psychosocial Intervention in HIV-Affected Children in Haiti$142,423
R21 · FY2006 · MH · contact PI
Psychosocial Intervention in HIV-Affected Children in Haiti$189,035
R21 · FY2005 · MH
CTL RESPONSE IN ACUTE HIV INFECTION$124,551
K08 · FY2001 · AI